본문 바로가기
KERD
논문KCI 등재

The association of leptin with severity of non-alcoholic fatty liver disease: A population-based study

Laura Rotundo|Alana Persaud|Mirela Feurdean|Sushil Ahlawat|Hyun-seok Kim
대한간학회 (The korean Association for the Study of the Liver)|2018.12|Clinical and Molecular Hepatology|제24권 제4호|pp. 392-401

1

조회

0

다운로드

3

인용

0

참고문헌

키워드

FibrosisLeptinNon-alcoholic fatty liver disease

초록

Background/Aims: Leptin is associated with metabolic disorders, which predispose one to non-alcoholic fatty liver disease (NAFLD). The role of leptin in NAFLD pathogenesis is not fully understood. We aim to investigate the association between serum leptin level and severity of NAFLD using U.S. nationally representative data. Methods: Data were obtained from the United States Third National Health and Nutrition Examination Survey. NAFLD was defined by ultrasound detection and severity of hepatic steatosis in the absence of other liver diseases. The severity of hepatic fibrosis was determined by NAFLD fibrosis score (NFS). We used multivariate survey-weighted generalized logistic regression to evaluate the association between leptin level and the degree of NAFLD. We also performed subgroup analyses by body mass index (lean vs. classic NAFLD). Results: Among 4,571 people, 1,610 (35%) had NAFLD. By ultrasound findings, there were 621 people with mild, 664 with moderate, and 325 with severe steatosis. There were 885 people with low NFS (<-1.455, no significant fibrosis), 596 with intermediate NFS, and 129 with high NFS (>0.676, advanced fibrosis). Leptin levels for normal, mild, moderate and severe steatosis were 10.7±0.3 ng/mL, 12.1±0.7 ng/mL, 15.6±0.8 ng/mL, 16±1.0 ng/mL, respectively (trend P-value<0.001). Leptin levels for low, intermediate, and high NFS were 11.8±0.5 ng/mL, 15.6±0.8 ng/mL, 28.5±3.5 ng/mL, respectively (trend P-value<0.001). This association remained significant even after adjusting for known demographic and metabolic risk factors. In the subgroup analysis, this association was only prominent in classic NAFLD, but not in lean NAFLD. Conclusions: Serum leptin level is associated with the severity of NAFLD, especially in classic NAFLD patients.

Abstract

Background/Aims: Leptin is associated with metabolic disorders, which predispose one to non-alcoholic fatty liver disease (NAFLD). The role of leptin in NAFLD pathogenesis is not fully understood. We aim to investigate the association between serum leptin level and severity of NAFLD using U.S. nationally representative data. Methods: Data were obtained from the United States Third National Health and Nutrition Examination Survey. NAFLD was defined by ultrasound detection and severity of hepatic steatosis in the absence of other liver diseases. The severity of hepatic fibrosis was determined by NAFLD fibrosis score (NFS). We used multivariate survey-weighted generalized logistic regression to evaluate the association between leptin level and the degree of NAFLD. We also performed subgroup analyses by body mass index (lean vs. classic NAFLD). Results: Among 4,571 people, 1,610 (35%) had NAFLD. By ultrasound findings, there were 621 people with mild, 664 with moderate, and 325 with severe steatosis. There were 885 people with low NFS (<-1.455, no significant fibrosis), 596 with intermediate NFS, and 129 with high NFS (>0.676, advanced fibrosis). Leptin levels for normal, mild, moderate and severe steatosis were 10.7±0.3 ng/mL, 12.1±0.7 ng/mL, 15.6±0.8 ng/mL, 16±1.0 ng/mL, respectively (trend P-value<0.001). Leptin levels for low, intermediate, and high NFS were 11.8±0.5 ng/mL, 15.6±0.8 ng/mL, 28.5±3.5 ng/mL, respectively (trend P-value<0.001). This association remained significant even after adjusting for known demographic and metabolic risk factors. In the subgroup analysis, this association was only prominent in classic NAFLD, but not in lean NAFLD. Conclusions: Serum leptin level is associated with the severity of NAFLD, especially in classic NAFLD patients.

참고문헌 (60)

  1. Fantuzzi G, "Leptin in the regulation of immunity, inflammation, and hematopoiesis", J Leukoc Biol, 68, pp.437~446 (2000)
  2. Angulo P, "Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease", J Hepatol, 41, pp.943~949 (2004)
  3. Testa R, "Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis", J Hepatol, 33, pp.33~37 (2000)
  4. Bouloumie A, "Leptin induces oxidative stress in human endothelial cells", FASEB J, 13, pp.1231~1238 (1999)
  5. Ikejima K, "Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals", Hepatology, 34, pp.288~297 (2001)
  6. Saxena NK, "Leptin as a novel profibrogenic cytokine in hepatic stellate cells : mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase(Erk)and Akt phosphorylation", FASEB J, 18, pp.1612~1614 (2004)
  7. Bedogni G, "Prevalence of and risk factors for nonalcoholic fatty liver disease : the Dionysos nutrition and liver study", Hepatology, 42, pp.44~52 (2005)
  8. Neuschwander‐Tetri BA, "Nonalcoholic steatohepatitis : summary of an AASLD Single Topic Conference", Hepatology, 37, pp.1202~1219 (2003)
  9. Lazo M, "The epidemiology of nonalcoholic fatty liver disease : a global perspective", Semin Liver Dis, 28, pp.339~350 (2008)
  10. Younossi ZM, "Global epidemiology of nonalcoholic fatty liver disease-Meta‐analytic assessment of prevalence, incidence, and outcomes", Hepatology, 64, pp.73~84 (2016)
  11. Kim HJ, "Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults", Arch Intern Med, 164, pp.2169~2175 (2004)
  12. Cruz ACD, "379. Characteristics and long-term prognosis of lean patients with nonalcoholic fatty liver disease", Gastroenterology, 46, pp.S-909~ (2014)
  13. Uygun A, "Serum leptin levels in patients with nonalcoholic steatohepatitis", Am J Gastroenterol, 95, pp.3584~3589 (2000)
  14. Dasarathy S, "Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis", Eur J Gastroenterol Hepatol, 23, pp.382~388 (2011)
  15. Saxena NK, "Leptin in hepatic fibrosis : evidence for increased collagen production in stellate cells and lean littermates of ob", ob mice, 2002, pp.35, 762~771
  16. Saxena NK, "Leptin induces increased alpha2(I)collagen gene expression in cultured rat hepatic stellate cells", J Cell Biochem, 89, pp.311~320 (2003)
  17. Elbadawy RA, "The role of leptin in non-alcoholic fatty liver disease", Saudi J Gastroenterol, 12, pp.68~72 (2006)
  18. Chitturi S, "Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?", Hepatology, 36, pp.403~409 (2002)
  19. Chalasani N, "Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis?", Am J Gastroenterol, 98, pp.2771~2776 (2003)
  20. "Plan and Operation of the Third National Health and Nutritional Examination Survey"[URL]
  21. Kim D, "Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States", Hepatology, 57, pp.1357~1365 (2013)
  22. Angulo P, "The NAFLD fibrosis score : a noninvasive system that identifies liver fibrosis in patients with NAFLD", Hepatology, 45, pp.846~854 (2007)
  23. Lin ZH, "Performance of the aspartate aminotransferase‐to‐platelet ratio index for the staging of hepatitis C‐related fibrosis : an updated meta‐analysis", Hepatology, 53, pp.726~736 (2011)
  24. "National Health and Nutrition Examination Survey III: Body Measurements (Anthropometry)"[URL]
  25. "Laboratory Procedures Used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994" (1996)[URL]
  26. Liangpunsakul S, "Serum vitamin D concentrations and unexplained elevation in ALT among US adults", Dig Dis Sci, 56, pp.2124~2129 (2011)
  27. Expert Panel on Detection, "Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)", JAMA, 285, pp.2486~2497 (2001)
  28. Ma Z, "Radioimmunoassay of leptin in human plasma", Clin Chem, 42(6 Pt 1), pp.942~946 (1996)
  29. "2013-2014 Data Documentation, Codebook, and Frequencies" (2015)[URL]
  30. Lumley T, "Analysis of complex survey samples", J Statistic Software, 9, pp.1~19 (2004)
  31. Angulo P, "Nonalcoholic fatty liver disease", N Engl J Med, 346, pp.1221~1231 (2002)
  32. Campbell B, "Females, Hispanics and older individuals are at greatest risk of developing metabolic syndrome in the US", Diabetes Metab Syndr, 10, pp.230~233 (2016)
  33. Crespo CJ, "Hypertension and other cardiovascular disease risk factors among Mexican Americans, Cuban Americans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey", Public Health Rep, 111(Suppl 2), pp.7~10 (1996)
  34. Brancati FL, "Incident type 2 diabetes mellitus in African American and white adults : the Atherosclerosis Risk in Communities Study", JAMA, 283, pp.2253~2259 (2000)
  35. Targher G, "Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?", Endocrine, 51, pp.211~221 (2016)
  36. Ayonrinde OT, "Gender‐specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease", Hepatology, 53, pp.800~809 (2011)
  37. Neuschwander‐Tetri BA, "Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease", Hepatology, 52, pp.913~924 (2010)
  38. Selthofer-Relatic K, "Leptin", adiponectin ratio in overweight patients - gender differences, 2018, pp.15, 260~262
  39. Liuzzi A, "Serum leptin concentration in moderate and severe obesity:relationship with clinical, anthropometric and metabolic factors", Int J Obes Relat Metab Disord, 23, pp.1066~1073 (1999)
  40. Ben Ali S, "Relationship of plasma leptin and adiponectin concentrations with menopausal status in Tunisian women", Cytokine, 56, pp.338~342 (2011)
  41. Tsochatzis EA, "Adipokines in nonalcoholic steatohepatitis : from pathogenesis to implications in diagnosis and therapy", Mediators Inflamm, 2009, pp.831670~ (2009)
  42. Lewis GF, "Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes", Endocr Rev, 23, pp.201~229 (2002)
  43. Paradis V, "High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis", Hepatology, 34(4 Pt 1), pp.738~744 (2001)
  44. Vos B, "Lean non-alcoholic fatty liver disease(Lean-NAFLD) : a major cause of cryptogenic liver disease", Acta Gastroenterol Belg, 74, pp.389~394 (2011)
  45. Visser ME, "Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia", Diabetologia, 54, pp.2113~2121 (2011)
  46. Rahimi AR, "The prevalence of celiac disease among patients with non-alcoholic fatty liver disease in Iran", Turk J Gastroenterol, 22, pp.300~304 (2011)
  47. Abenavoli L, "A pathogenetic link between non-alcoholic fatty liver disease and celiac disease", Endocrine, 43, pp.65~67 (2013)
  48. Staufer K, "Cystic fibrosis related liver disease--another black box in hepatology", Int J Mol Sci, 15, pp.13529~13549 (2014)
  49. Margariti E, "Non-alcoholic fatty liver disease may develop in individuals with normal body mass index", Ann Gastroenterol, 25, pp.45~51 (2012)
  50. Kumar R, "Clinicopathological characteristics and metabolic profiles of nonalcoholic fatty liver disease in Indian patients with normal body mass index: do they differ from obese or overweight non-alcoholic fatty liver disease?", Indian J Endocrinol Metab, 17, pp.665~671 (2013)
  51. Ikejima K, "Expression of leptin receptors in hepatic sinusoidal cells", Comp Hepatol, (3 Suppl 1), pp.S12~ (2004)
  52. Joseph AE, "Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease", Clin Radiol, 43, pp.26~31 (1991)
  53. Brunt EM, "Nonalcoholic steatohepatitis : definition and pathology", Semin Liver dis, 21, pp.3~16 (2001)
  54. Brunt EM, "Nonalcoholic steatohepatitis : a proposal for grading and staging the histological lesions", Am J Gastroenterol, 94, pp.2467~2474 (1999)
  55. Puustinen L, "Prognostic value of clinical variables and liver histology for development of fibrosis and cirrhosis in autoimmune hepatitis", Scand J Gastroenterol, 52, pp.321~327 (2017)
  56. Adams LA, "The natural history of nonalcoholic fatty liver disease : a population-based cohort study", Gastroenterology, 129, pp.113~121 (2005)
  57. Ong JP, "Increased overall mortality and liverrelated mortality in non-alcoholic fatty liver disease", J Hepatol, 49, pp.608~612 (2008)
  58. Polyzos SA, "Circulating leptin in non-alcoholic fatty liver disease : a systematic review and meta-analysis", Diabetologia, 59, pp.30~43 (2016)
  59. Saverymuttu SH, "Ultrasound scanning in the detection of hepatic fibrosis and steatosis", Br Med J(Clin Res Ed), 292, pp.13~15 (1986)
  60. Hernaez R, "Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver : a meta‐analysis", Hepatology, 54, pp.1082~1090 (2011)

관련 논문AI추천

Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular diseaseDimitrios Patoulias, Konstantinos Imprialos, Konstantinos Stavropoulos, Michael Doumas대한간학회 · Clinical and Molecular Hepatology2019 · 제25권 제3호비알콜성 지방간에서 간조직 손상과 혈중 렙틴의 연관성김경오, 김동준, 김종혁, 박상훈, 박철희, 박충기, 유교상, 이명석, 조현득, 한태호대한간학회 · Clinical and Molecular Hepatology2005 · 제11권 제2005호Comparison between obese and non-obese nonalcoholic fatty liver diseaseWah-Kheong Chan대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제1호Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease김혜순, Ahn Sang Hoon, Cha Bong-Soo, Han Eugene, Kang Eun Seok, Kim Beom Kyung, Kim Do Young, Kim Mi Kyung, Kim Seung Up, Kim Yuna, Lee Byung-Wan, Lee Hye Won, Lee Jae Seung, Lee Yong-ho, Park Jun Yong거트앤리버 소화기연관학회협의회 · Gut and Liver2022 · 제16권 제2호The Role of Inflammatory Mediators in the Pathogenesis of Nonalcoholic Fatty Liver Disease김준성대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2012 · 제15권 제2호Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes김순선, 정재연, 조효정, Chun Ho Soo, Kim Ja Kyung, Kim Seung Up, Lee Minjong, Lim Tae Seop거트앤리버 소화기연관학회협의회 · Gut and Liver2023 · 제17권 제4호

이 간행물의 다른 논문 (12건)

Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals고순영, 최원혁pp. 351-357Severe acute alcoholic hepatitis and liver transplant: A never-ending mournful storySteffen Stern, Aiman Obed, Abdalla Bashir, Anwar Jarradpp. 358-366Assessment of fibrotic burden among chronic hepatitis B virus-infected patients with normal transaminase levelMi Young Jeon, 김범경, 김승업pp. 367-369Rehabilitation for social reintegration in liver transplant patients김종만pp. 370-371Cirrhotic cardiomyopathy: An independent prognostic factor for cirrhotic patientsYun Bin Lee, Jeong-Hoon Leepp. 372-373
원문 보기